Phase 2 MET Exon 14 Skipping Mutation Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
Non-small Cell Lung CancerMET AmplificationBRAF V600 Mutation+3 more
Guangdong Provincial People's Hospital30 enrolled1 locationNCT05800340
Completed
Phase 2
Cancer Molecular Screening and Therapeutics (MoST) Program Addendum 17 - substudies 38-39: Tepotinib
Advanced non-small cell lung cancer harbouring MET exon 14 skipping mutations
The University of Sydney32 enrolled12 locationsACTRN12621000811808